The prevalence of healthcare-associated infections (HAIs) caused by multidrug-resistant organisms has significantly increased over the past decade, according to the measurements of the Centers for Disease Control and Prevention, and will likely continue to climb. 1 ' 2 Currently, more than 70% of HAIs are caused by bacteria that are resistant to at least 1 of the drugs most commonly used to treat these infections. 3 These HAIs have been associated with increased cost and mortality, compared with infections due to antibiotic-susceptible strains of the same bacterial species. 4,5 Nevertheless, despite decades of studies confirming increased rates of adverse events related to these organisms and ongoing evidence of increased prevalence of multidrug-resistant organisms, 2 as well as the emergence of new antimicrobial-resistant organisms, 6 few coordinated effective efforts exist across the United States and most parts of the world to prevent MRSA transmission and reduce the number of MRSA HAIs. 7 Despite evidence of efficacy for control of multidrug-resistant organisms with active surveillance cultures and barrier precautions 8 " 10 and despite documented failure to control MRSA in studies lacking methods to fully identify the MRSA reservoir, 8 most healthcare systems have not elected to implement methods to identify and contain MRSA, and so MRSA continues to spread and to colonize and infect patients.
Several studies in this issue of Infection Control and HospitalEpidemiology describe efforts to control methicillin-resistant S. aureus (MRSA). I comment here on 3 of them. 11 " 13 Interestingly, the investigators in these 3 studies believe that colonized patients represented a significant portion of the MRSA reservoir and elected to implement a program of active surveillance cultures to better identify MRSA-colonized patients. In two of the studies, that of Salgado and Farr 11 and that of Eveillard et al., 12 barrier precautions were implemented for all patients identified as being MRSA colonized, as recommended by the recent Society for Healthcare Epidemiology of America (SHEA) guideline. 8 The third study, by Sandri et al., 13 discusses the utility of MRSA decolonization of the nares by administration of topical mupirocin therapy and chlorhexidine baths to all patients identified as having MRSA colonization of the nares.The study by Salgado and Farr" reports the proportion of patients identified by active surveillance culture on admission as being MRSA colonized who later had an MRSA-positive clinical microbiology culture, the number and type of clinical microbiology cultures done, and the number and type of MRSA-positive clinical microbiology cultures. Their study demonstrates that only 15% of all patients identified as being colonized with MRSA on admission would have been so identified subsequently via clinical microbiology culture. When data for patients in the intensive care unit (ICU) and in other units (non-ICU patients) were analyzed separately, the investigators found that 21.4% of ICU patients had a subse...